MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by targeting the super-enhancer-regulated gene SDC1 in Glioblastoma [ChIP-Seq]
Ontology highlight
ABSTRACT: MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by targeting the super-enhancer-regulated gene SDC1 in Glioblastoma [ChIP-Seq]
PROVIDER: PRJNA1025848 | ENA |
REPOSITORIES: ENA
ACCESS DATA